Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Sanara MedTech Inc. Common Stock (SMTI)

Orthopedic, Prosthetic & Surgical Appliances & Supplies

https://www.sanaramedtech.com

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser and BIAKOS Skin and Wound Gel.

1200 SUMMIT AVE, SUITE 414
FORT WORTH, TX

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/02/2020

Market Cap

288,519,135

Shares Outstanding

8,540,000

Weighted SO

8,538,489

Total Employees

N/A

Upcoming Earnings

08/12/2024

Similar Tickers

INFU --.--%

PDEX --.--%

LMAT --.--%

UTMD --.--%

MLSS --.--%

DXR --.--%

MHUA --.--%

KRMD --.--%

Beta

1.5920

Last Div

0.0000

Range

26.0-43.25

Chg

-0.0250

Avg Vol

21616

Mkt Cap

288519135

Exch

NASDAQ

Country

US

Phone

817 529 2300

DCF Diff

71.2223

DCF

-34.2223

Div Yield

0.0000

P/S

3.9845

EV Multiple

-75.3774

P/FV

6.6979

Div Yield %

0.0000

P/E

-42.5456

PEG

-0.8679

Payout

0.0000

Current Ratio

1.7994

Quick Ratio

1.4912

Cash Ratio

0.5318

DSO

53.4677

DIO

121.1007

Op Cycle

174.5685

DPO

30.4403

CCC

144.1282

Gross Margin

0.8516

Op Margin

-0.1047

Pretax Margin

-0.0923

Net Margin

-0.0907

Eff Tax Rate

0.0667

ROA

-0.0895

ROE

-0.1508

ROCE

-0.1227

NI/EBT

0.9821

EBT/EBIT

0.8816

EBIT/Rev

-0.1047

Debt Ratio

0.2012

D/E

0.3540

LT Debt/Cap

0.2563

Total Debt/Cap

0.2615

Int Coverage

-76.7832

CF/Debt

-0.1890

Equity Multi

1.7595

Rec Turnover

6.8265

Pay Turnover

11.9907

Inv Turnover

3.0140

FA Turnover

24.8942

Asset Turnover

0.9867

OCF/Share

-0.3295

FCF/Share

-0.3708

Cash/Share

0.7262

OCF/Sales

-0.0385

FCF/OCF

1.1251

CF Coverage

-0.1890

ST Coverage

-7.0890

CapEx Coverage

-7.9922

Div&CapEx Cov

-7.9922

P/BV

6.6979

P/B

6.6979

P/S

3.9845

P/E

-42.5456

P/FCF

-91.8889

P/OCF

-100.0986

P/CF

-100.0986

PEG

-0.8679

P/S

3.9845

EV Multiple

-75.3774

P/FV

6.6979

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 03, 09:15 Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides GlobeNewswire Inc. Nov 30, 09:15 Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound Healing GlobeNewswire Inc. Oct 30, 09:15 Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates

Revenue Product Segmentation